(1S,2S,3R,5S)-(+)-2,3-Pinanediol CAS 18680-278 ee ≥99.0% Puritas ≥99.0% Bortezomib Intermedia High Puritas
Copia Bortezomib intermedia cum High puritate
(1S,2S,3R,5S)-(+)-2,3-Pinanediol CAS 18680-27-8.
(1R,2R,3S,5R)-(-)-2,3-Pinanediol CAS 22422-34-0
Bortezomib CAS 179324-69-7
| Nomen chemicum | (1S,2S,3R,5S)-(+)-2,3-Pinanediol |
| Synonyma | (1S,2S,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptane-2,3-diol. |
| CAS Number | 18680-278 |
| CATTUS Number | RF-CC290 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C10H18O2 |
| M. Pondus | 170.25 |
| Solubilitas | Chloroform, Toluene |
| Shipping Condition | Uit sub Ambient Temperature |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | White ad Off-White Crystallized pulveris |
| Liquescens punctum | 56.0~59.0℃ |
| Damnum in Siccatio | ≤0.50% |
| Residere in Ignition | ≤0.50% |
| Enantiomeric Excessus | ee≥99.0% |
| Puritas / Analysis Methodus | ≥99.0% (GC) |
| Imprimis rotationis [α]20/D | +8.5° ad +9.5° (C=6.5, Toluene) |
| Infrared Imaginis | Conforms |
| Test Standard | Enterprise Standard |
| Consuetudinem | Chiral Compositions;Pharmaceutical Intermedia;Bortezomib medium |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum (1S,2S,3R,5S)-(+)-2,3-Pinanediol (CAS 18680-27-8) magna qualitate, late organicis adhibitis. synthesis, synthesis intermediorum pharmaceuticorum et synthesis chemicae tenuis.
Shanghai Ruifu Chemical Co, Ltd. magni ponderis munus agit in chymiae chiralae, societas commissa productioni compositionum chiralium.Nostri fructus a clientibus late laudantur.
(1S,2S,3R,5S)-(+)-2,3-Pinanediol (CAS 18680-27-8), utilis est reagens chiralis adhibita in synthesi homochiralis α-hydroxyketonum et in solutione esters prolineboronatus.Utile etiam est praecursori ad allyl boronatum chiralum adhibitum in praeparatione chiralis aba hydroxyallylsilanes.
(1S,2S,3R,5S)-(+)-2,3-Pinanediol (CAS 18680-27-8) medium est Bortezomib (CAS 179324-69-7) in tractatione Myeloma Multiplici.Bortezomib, potens ubiquitin proteasome (26S) inhibitor (Ki=0.6 nM), in US tractandi causa multiplex myeloma inmissus est.Hoc proteasome requiritur ad degradationem proteolyticam maioris servo cellulosi et in omnibus cellulis adest.Requiritur moderatio processuum inflammationis, cycli celi ordinatio et expressionis gene, et novum signum in curatione cancri est.
